Cover VA, a division of the Virginia Department of Medicaid Assistance Services (DMAS), connects eligible Virginians to high-quality, affordable health insurance.
Advancing science for life is at the core of all we do at Boston Scientific. Our products treat and prevent a broad range of conditions that can diminish a person’s quality of life, including stroke.
Before SARS-CoV-2, Aegis Sciences Corporation was a small, well-established lab with a specific niche. Founded in 1990, the Nashville-based company focused on anti-doping testing and medication compliance.
Since the pledge, Gilead has continued its long history in supporting reducing deaths from VL and controlling other neglected tropical diseases such as cryptococcal meningitis in efforts to advance global health equity.
Dr. Shringar Rao’s inquisitive nature and dedication to addressing health inequities drive her eagerness to help advance innovative scientific breakthroughs.
Claudia Hardy says she’s found her life’s mission. As director of Community Health Access and Relations for the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, she brings cancer resources and preventive care to communities.
Abbott (NYSE: ABT), a global leader in heart health, announced today the Abbott HeartMates program, a new initiative that will kick off with professional football player Damar Hamlin as its first ambassador.
In the pursuit of changing the narrative around substance use disorder to reduce the stigma, Craig Melvin, TODAY Show host and speaker at a recent Advertising Week New York (AWNY) panel.
The Ad Council, in partnership with the Centers for Disease Control and Prevention (CDC), National Council for Mental Wellbeing and Shatterproof, is inspiring millions to "Start With Hope” in a national public service advertisement (PSA) campaign.
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, announced today it is hosting The Power of Partnership to Address Antimicrobial Resistance (AMR), a Nasdaq webinar that will air on Tuesday, November 14, 2023 at 9 a.m. ET.
We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - disease areas with vulnerable patient populations who are often treated in public health.
As sustainability leaders, we implement our sustainability strategy across all company activities along the entire value chain, from raw materials to...
Entergy’s 2024 performance report, “Energy for a better future” presents an overview of our company’s 2024 achievements, future plans and strategies...
